American Association for the Advancement of Science, Science Immunology, 64(6), 2021
DOI: 10.1126/sciimmunol.abj2901
Full text: Unavailable
Preexisting cross-coronavirus immunity influences the early development of SARS-CoV-2 humoral immunity after COVID-19.